Attralus
Biotechnology ResearchView the employees at
Attralus-
Alex Sienkiewicz Director of Process Development and Manufacturing
-
San Diego, California, United States
-
Rising Star
Mike Klein Biopharmaceutical CMC Executive-
Los Angeles Metropolitan Area
-
Top 5%
Akari Yamagami Director, Statistical Programming at Attralus-
Rising Star
Overview
Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Our proprietary pan-amyloid removal (PAR) therapeutics are designed to directly bind to and remove toxic amyloid in organs and tissues. By targeting the universal disease-causing pathology in all systemic amyloidosis diseases, PAR therapeutics have the potential to treat and reverse disease in patients with all types and stages of systemic amyloidosis.
-